Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Congratulations to the NEW Dr. Eline C. H. M. Haijen!
After successfully defending her PhD thesis entitled: “Exploring the Adult ADHD Treatment Landscape: From Current Practices to Psychedelic Microdosing and Novel Screening Approaches.” In her thesis, she looks at novel approaches of treating ADHD with LSD microdosing.
Watch the defense here!Congratulations to Lilian Kloft-Heller for being awarded the Collaborative Innovative Projects grant
From The Science Committee of the Faculty of Law for her research titled "Effects of Intoxication on Legal Decision-Making in Suspects: Developing Experimental Tools Using Virtual Reality"
Across two studies, Lilian will assess how intoxicated suspects make decisions on their rights and strategies throughout the custodial process. One study will be a field study in which self-intoxicated participants (alcohol) will take part. This study will be conducted in a bar or at a festival. The second study is a lab experiment to examine effects of acute cannabis intoxication on suspect decision-making.
Meet our Department!
The scientists in our lab come from many countries and backgrounds, all with highly unique research abilities. Come meet the people that make up the Psychopharmacology Department.
Learn MoreParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Dr. C. Rob Markus
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
Zeus Tipado, MSc
My neuroscience research is focused on perceptual experiences of psychedelics, specifically visual experiences while under DMT.
Dr. Conny Quaedflieg
Stress Resilience, Intentional Forgetting, EEG
Through my extensive research experience, I have built expertise in various disciplines (psychology, psychophysiology, neurosciences) and I have become enthusiastic about bridging them.
Iva Totomanova, MSc
My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.
Dr. Rudy Schreiber
CNS Drug Discovery, Research Domain Criteria
I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies
Dr. Eef Theunissen
Synthetic Cannabinoids, Drugs and Driving, Cognition
I began my Ph.D. journey in 2001 at the Faculty of Psychology at the University of Maastricht. My research focused on investigating the sedating and stimulating effects of antihistamines, with a particular emphasis on their...
Dr. Kim Kuypers
Microdosing, Cognition, Nutrition
My research focuses on the neurobiology of flexible cognition, empathy, and well-being.
Pablo Mallaroni, MSc
Psychedelics, fMRI/MRS, Idiosyncracy
I am PhD candidate with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.
Dr. Johannes Reckweg
Therapy, 5-MeO-DMT, Neuropsychopharmacology
I am Johannes, a PhD from Germany. After receiving my Bachelor’s degree from the Rijksuniversiteit Groningen, I came to Maastricht for my Master in Neuropsychology.
Psychedelic Research
Spontaneous and deliberate creative cognition during and after psilocybin exposure
creativity, Psilocybin, Cognition
→
Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study
→
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
divergent thinking, Ayahuasca, convergent thinking, creativity
→
Cannabis Research
Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans
→
Cognition and motor control as a function of 9-THC concentration in serum and oral fluid: Limits of impairment
→
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.